| Literature DB >> 20610012 |
Abstract
Pimobendan is a drug with both inotropic and vasodilatory properties and is widely used for the treatment of heart failure in dogs. The best evidence regarding its efficacy is derived from several clinical studies of dogs with the two most common conditions that result in heart failure: dilated cardiomyopathy (DCM) and degenerative mitral valve disease (DMVD). The main studies addressing the effectiveness of pimobendan in dogs with DCM and DVMD are discussed in this article.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20610012 DOI： 10.1016/j.cvsm.2010.04.003
Source DB: PubMed Journal: Vet Clin North Am Small Anim Pract ISSN： 0195-5616 Impact factor: 2.093